IBL 20 mW

DEVICE2 trials

Sponsors

DUSA Pharmaceuticals, Inc.

Conditions

Actinic Keratosis

Phase 2

Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

CompletedNCT02632110

DUSA Pharmaceuticals, Inc.Actinic Keratosis

Start: 2016-03-31End: 2016-09-12Updated: 2018-01-18

Phase 3

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

WithdrawnNCT03024060

DUSA Pharmaceuticals, Inc.Actinic Keratosis

Start: 2017-03-31End: 2018-01-31Updated: 2017-11-07